The Deal magazine looks at the biotech sector and how new, creative funding deals are promising to rejuvenate the search for new drugs. Plus, this issue looks at LIBOR's new landscape. Meanwhile, we have an indepth conversation with CD&R's Joseph Rice.June 18, 2012
What goes up must come down, and so it would appear as The Deal magazine examines big-league bankruptcy. The theory holds for Tribune as it's new owners weigh its assets. But what about W.R. Grace, as it emerges from bankruptcy having made 22 acquisitions under protection? Plus, the corporate dealmaker 100.May 28, 2012
The Deal magazine takes an indepth look at the strategic dealmaking of the packaging industry in the middle market. We also hit the road looking at the startup landscape in the drug development and medical devices sectors in Kalamazoo, Michigan as well as the burgeoning companies in the solar power, pharmaceutical, brewery and pesticide industries in Bend, Oregon.May 7, 2012
Wanna do M&A? Careful, because here comes the shareholder litigation. When it comes to tech acquisitions, they're getting done -- just too bad companies aren't very good at it. And sovereign wealth funds are back, growing fast.April 16, 2012
No one said private equity would be easy, and our annual Private Equity Deals of the Year proves it again with a roundup of 2011's big winners and losers. Also, The Deal magazine takes a look at cowboy capitalism with a trip to Dallas-Fort Worth. Finally, take a look at our sampling of middle-market companies on the auction block.April 2, 2012
The Deal magazine travels to Japan to witness the island nation rise again amidst an active streak of dealmaking. Plus, a duet of music-related articles look at the antitrust snares of Universal Music's purchase of EMI assets and the effect that the emergence of digital music is having on copyright laws.March 12, 2012
In this issue, The Deal magazine hits the bankruptcy trifecta: the take-no-prisoners battle for Alter Communications; the rise and fall of real estate moguls, the Meruelo brothers; and the bankruptcy league tables. Also, take a look at how Humana has set a new course along the acquisition trail.February 20, 2012
The Deal magazine focuses on the middle market by looking at some of its top dealmakers and then gives an overview of what's out there on the auction block. The issue also features an in-depth look at private equity in France and in emerging markets around the world.February 6, 2012
The Deal magazine gets in the pilot seat to take a look at American Airlines' bankruptcy, then wonders what will now happen to a beleaguered Reader's Digest. Also, Herb Fritch of HealthSpring may have an answer to the sky-high inflation of the healthcare industry.January 23, 2011
What a topsy-turvy, rumbly-tumbly year 2011 turned out to be -- and The Deal magazine takes a look at the M&A Deals of the Year in uncertain times. Also, Edgar Bronfman Jr. sits down for his first interview since selling Warner Music.December 12, 2011
Just when you thought it was safe to go back in the water, suddenly it was 2011 -- and The Deal magazine looks back at all the twists and turns of dealmaking. Also in this issue, dealmakers pay back as social entrepreneurs.November 28, 2011
'What worrying wall of debt?' The Deal magazine asks. Oh, right, there it is. Plus, the Windy City offers up its own particular brand of private equity, while, farther afield, Big Oil makes a play in Kurdistan.November 14, 2011
The Deal magazine tracks down the in-house corporate dealmakers from the top American companies and takes a voyage around the world to explore the valleys and peaks of the travel industry.October 31, 2011
The Deal magazine goes back to school and offers a full report on the business of education.October 17, 2011
The Deal magazine goes looking for trolls and geeks, and the middle market shows its ups and downs in a trying economy.October 3, 2011
Who are the private equity movers and shakers to keep an eye on, and how does Ralph de la Torre look to transform managed care?September 19, 2011
The Deal magazine honors this year's Most Admired Corporate Dealmakers and takes a close look at the ups and downs of Wall Street compensation.September 5, 2011
The interview issue asks all the pertinent questions to six experts in their respective fields, while the market for multiple sclerosis therapies provides an evocative case study on dealmaking.July 25, 2011
The Deal magazine gets up close and personal with faces of the middle market and charts the new hits of the music business as it shifts away from label dominance.June 27, 2011
Despite trying financial times, the spotlight shines on the private equity deals of the year that were deftly executed and held to the principle of creating value.
Ariel Deckelbaum, a partner at Paul, Weiss' shares his thoughts regarding the influence of activist investors on the sale of a company, notably in the case of Carl Icahn's push for the sale oil refiner CVR Energy Inc.
Although hit hard by the job losses after the acquisition of Upjohn, the city of Kalamazoo, Michigan, has rebounded and remains a major center for biotech research.
We profile five of them who have gained fame and fortune mastering the complex art of selling companies.
The investment banker has razor-sharp instincts for the right buyer for a particular asset.
The private equity banking chief has made a name for his company in only 23 months on the job.
The investment banker has made quick work of some of the largest energy transactions since coming on board from Scotia Waterous in June 2011.
The head of the Japanese bank's U.S. acquisition finance group was its point person on KKR's LBO of Samson Investment, where he worked mostly below the radar.
The energy investment banker says private equity in the energy sector is here to stay.
The author of 'Private Empire: ExxonMobil and American Power' discusses the oil giant and its approach to dealmaking.
Steve Coll dissects the personalities and connections behind the oil giant's deal for XTO.
The investment bank's head of emerging-markets equities coverage discusses his new book.
The head of the PE firm's European origination team is looking for good companies at low valuations amid Europe's economic turmoil.
When allegations of insider trading bedeviled him, the House Financial Services Committee's top Republican knew just who to call.
Andrews Kurth enters uncharted territory for CEI, Wolverine and PE firms put their best foot forward for Collective Brands, and printed circuit board rivals unite.
The new interim CEO brings a completely different set of skills to the table than his predecessor.
Venerable listed buyout shop 3i faces serious issues, but its new CEO is starting from a better place than investors acknowledge.
Hirings, firings, raids, defections, new offices, retirements and fond remembrances when appropriate.
Cardboard boxes, metal cans, flexible plastic, multilayered wrapping, even old-fashioned glass. Packaging can be commoditized or high tech, which makes it a major source of strategic and financial dealmaking, particularly in the middle market.
This small city in bucolic Michigan would hardly seem to be a hotbed of drug development and medical devices. But after a near-death experience, it has rediscovered the entrepreneur and the startup.
Bend is home to burgeoning companies in the solar power, pharmaceutical, brewery and pesticide industries.
Every year, thousands of middle-market companies go up for sale. Here's a sampling of what's out there right now.
Against the debate over the skyrocketing cost of an education come homilies about frugality. Still, there's a big difference between saving as a sport and saving as a reality.
Is there a magic bridge between short and long, past and future, microfoundation and macroeconomics?
The IAC/InterActiveCorp chief extends a career of disruption by backing Aereo, a startup that threatens to turn network TV upside down.
The Delaware vice chancellor seeks to resolve a case in which a large group of plaintiffs objected to a settlement to which two of them initially agreed.
Regulators like it, but companies in cross-border deals should think twice before agreeing to waivers.
With Carlyle's IPO, the big buyout shops that showed an interest in going public have done so. Time to assess the damage.
2012 may bring the long-anticipated breakthrough in private investment that industry analysts have been looking for.
Recent market turbulence, a lack of transparency in transaction data, and a myriad of assumptions with respect to growth prospects and tax code changes have made the valuation process more difficult.
The reporting form for private fund advisers was mandated by the Dodd-Frank Act to help regulators determine systemic risk.